Physician

Jeffrey M Kaplan, M.D.

According to 2025 Medicare claims, Jeffrey Kaplan, M.D. (NPI: 1730176041) practices neurology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is SHAWNEE MISSION MEDICAL CENTER INC (NPI: 1992735690; TIN: 560543246) and primary practice location at 66205-2515. Kaplan is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), participating under the MSSP model.

Kaplan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 204 traditional Medicare patients, billed 74,053 HCPCS/CPT codes, and received $947,367 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 782 prescription claims across 136 beneficiaries totaling $1,102,649 in drug costs, led by Dalfampridine Er (Dalfampridine). 2020 DME data shows 30 claims. Open Payments data shows 408 records totaling $713,130. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $308,203 to $947,367. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $474,619 to $1,102,649. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,454 to $1,552.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	171	35,531	$308,203
2016	221	42,561	$494,320
2017	239	50,261	$651,801
2018	231	60,762	$635,620
2019	235	82,618	$1,075,357
2020	173	68,390	$797,672
2021	172	62,724	$1,008,437
2022	191	73,391	$894,782
2023	191	71,112	$895,172
2024	204	74,053	$947,367

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	149	993	$474,619
2016	169	1,022	$317,128
2017	149	853	$437,782
2018	156	843	$498,121
2019	187	1,325	$1,277,620
2020	147	810	$1,014,509
2021	118	739	$647,935
2022	136	873	$1,131,348
2023	120	692	$1,050,157
2024	136	782	$1,102,649

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	37	$1,547
2016	20	42	$2,911
2017	15	17	$1,214
2018	11	11	$848
2019	N/R	N/R	N/R
2020	12	30	$1,360
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	90	135	$130
64615	Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face	57	184	$113
95806	Sleep study including heart rate, breathing, airflow, and effort	42	42	$33
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	33	37	$13
J0585	Injection, onabotulinumtoxina, 1 unit	65	41,387	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dalfampridine Er	Dalfampridine	18	600	$6,994
Myrbetriq	Mirabegron	16	480	$6,632
Pyridostigmine Bromide	Pyridostigmine Bromide	15	684	$5,569
Gabapentin	Gabapentin	59	3,545	$2,170
Carbamazepine	Carbamazepine	26	676	$1,923

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	310	$282,847	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	98	$430,282	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey M. Kaplan, M.D.?

Tedicare shows public-source Medicare data for Jeffrey M. Kaplan, M.D. (NPI 1730176041), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey M. Kaplan, M.D. have ACO affiliation data?

Jeffrey M. Kaplan, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287).

What billing organization is linked to Jeffrey M. Kaplan, M.D.?

Jeffrey M. Kaplan, M.D. is linked to SHAWNEE MISSION MEDICAL CENTER INC (billing NPI 1992735690) in the available physician profile data.

Does Jeffrey M. Kaplan, M.D. have Open Payments data?

Jeffrey M. Kaplan, M.D. has 408 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.